These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1880899)

  • 1. Clinical experience in patients with implantable cardioverter defibrillators.
    Tsuji H; Shahian DM; Venditti FJ
    Jpn Circ J; 1991 Jul; 55(7):669-75. PubMed ID: 1880899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation.
    Kou WH; Kirsh MM; Bolling SF; Stirling M; Kadish AH; De Buitleir M; Calkins H; Lewis RR; Morady F
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1586-92. PubMed ID: 1721147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator.
    Manolis AS; Tan-DeGuzman W; Lee MA; Rastegar H; Haffajee CI; Huang SK; Estes NA
    Am Heart J; 1989 Sep; 118(3):445-50. PubMed ID: 2773768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome with the automatic implantable cardioverter-defibrillator.
    Winkle RA; Mead RH; Ruder MA; Gaudiani VA; Smith NA; Buch WS; Schmidt P; Shipman T
    J Am Coll Cardiol; 1989 May; 13(6):1353-61. PubMed ID: 2703616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease.
    de Marchena E; Chakko S; Fernandez P; Villa A; Cooper D; Wozniak P; Cruz J; Thurer RJ; Kessler KM; Myerburg RJ
    Am J Cardiol; 1991 Apr; 67(9):812-6. PubMed ID: 2011982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
    Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB
    J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved patient surveillance and data acquisition with a third generation implantable cardioverter defibrillator.
    Luceri RM; Puchferran RL; Brownstein SL; Habal SM; David IB; Vardeman LL
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1870-4. PubMed ID: 1721191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of left ventricular function on outcome of patients treated with implantable defibrillators.
    Kim SG; Fisher JD; Choue CW; Gross J; Roth J; Ferrick KJ; Brodman R; Furman S
    Circulation; 1992 Apr; 85(4):1304-10. PubMed ID: 1555274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with a second-generation cardioverter-defibrillator].
    Meyer BJ; Candinas R; Gloor HO; Bertel O; Amann FW; Turina MI
    Schweiz Med Wochenschr; 1991 Nov; 121(46):1701-5. PubMed ID: 1957143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death.
    Reid PR; Mirowski M; Mower MM; Platia EV; Griffith LS; Watkins L; Bach SM; Imran M; Thomas A
    Am J Cardiol; 1983 Jun; 51(10):1608-13. PubMed ID: 6858865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
    Marchlinski FE; Flores BT; Buxton AE; Hargrove WC; Addonizio VP; Stephenson LW; Harken AH; Doherty JU; Grogan EW; Josephson ME
    Ann Intern Med; 1986 Apr; 104(4):481-8. PubMed ID: 3954276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The automatic implantable cardioverter-defibrillator. Clinical experience, complications, and follow-up in 25 patients.
    Borbola J; Denes P; Ezri MD; Hauser RG; Serry C; Goldin MD
    Arch Intern Med; 1988 Jan; 148(1):70-6. PubMed ID: 3337605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implantable cardioverter-defibrillator: clinical results.
    Palatianos GM; Thurer RJ; Cooper DK; Georgakakis GE; Tucker RL; Fernandez P; Interian A; Myerburg RJ
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):297-301. PubMed ID: 1706841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with a new implantable pacer-, cardioverter-defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias: a step toward a universal ventricular tachyarrhythmia control device.
    Fromer M; Schläpfer J; Fischer A; Kappenberger L
    Pacing Clin Electrophysiol; 1991 Aug; 14(8):1288-98. PubMed ID: 1719507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.